BIOGEN IDEC

Related by string. Biogen Idec * BioGen : sanofi aventis Biogen Idec / Idec : Biogen Idec Elan * CAMBRIDGE Mass. Biogen Idec . Biogen Idec creates . Biogen Idec nasdaq BIIB . Biogen Idec BIIB . Biogen Idec NASDAQ BIIB . therapies Biogen Idec . Biogen Idec Tysabri . Biogen Idec Nasdaq BIIB . Tysabri Biogen Idec . Biogen Idec Avonex . Biogen Idec Inc BIIB.O . Biogen Idec Inc *

Related by context. Frequent words. (Click for all words.) 76 THERAPEUTICS 75 TREATMENT OF 74 DETECTS BULLISH HARAMI PATTERN 74 BEST GENERIC TABS 73 TRADING HIGHER ON #.#X 73 BUY CHEAPEST PILLS ONLINE 73 INC. ANNOUNCES 72 SMARTREND 'S OPTION SCANNER 72 DETECTS BEARISH HARAMI PATTERN 72 APPOINTS NEW 72 REPORTED IN 72 PRAECIS PHARMACEUTICALS INCORPORATED 72 DOWNWARD MOMENTUM LOOKS TO 72 THE TREND CONTINUES LOWER 71 CAPABILITIES 71 THE LOWEST 71 SMARTREND DETECTS CONTINUED SELLING 71 AND THOSE 71 HAS RETURNED 71 DETECTS BEARISH ENGULFING PATTERN 71 THE TREND CONTINUES DOWN 71 PHARM 71 PHARMACEUTICALS 71 MAY CAUSE 71 'S QUARTERLY RESULTS 71 TARGET FOR 71 DOWNTREND SPOTTED IN SHARES 71 EARNINGS UPDATE 71 'S SHARES CHANGING 71 BIOTECHNOLOGY 71 DRRX 71 TO EBITDA RATIO 70 THE COURIER JOURNAL 70 SMARTREND RESEARCH REPORT AVAILABLE 70 DETECTS UNUSUAL ACTIVITY IN 70 PATTERN FOR 70 IS EXPECTED TO BEAT 70 WATCH FOR CONTINUED GAINS 70 DAYS AGO 70 CASINI 70 INTEREST OF 70 UPWARD MOMENTUM LOOKS TO 70 ANNOUNCED FOR 70 SHARES CREEPING HIGHER UP 70 RELEASES ITS QUARTERLY EARNINGS 70 DETECTS BULLISH ENGULFING PATTERN 70 MOVE INTO 70 GROWTH IN THE 70 POTENTIALLY UNDERVALUED IN TERMS 70 HIGHLIGHTS OF 70 ANY SUCH 70 WHAT DO YOU LIKE 70 SUCCESS FOR 70 MOVES INTO NEW 70 SCHEDULED FOR 70 co name = 70 THE TREND CONTINUES UP 70 OUTLINES 70 SMARTREND DETECTS POTENTIAL BREAK 70 REACHES INITIAL SUPPORT LEVEL 70 WEEK HIGH RECENTLY ECLIPSED 70 STOCK TO WATCH 70 SMARTREND VINDICATED ON 70 WILL BE ABLE TO 69 TO REBOUND AFTER 69 BUYERS ACCUMULATE SHARES OF 69 OUT IN SHARES 69 TO PARTICIPATE IN 69 BREAKS THROUGH RESISTANCE AT 69 THE TREND CONTINUES HIGHER 69 WILL BE REPORTED IN 69 PHARMACEUTICALS INC. 69 BREAKS THROUGH SUPPORT 69 NEXT SUPPORT LEVEL FOR 69 WILL OCCUR 69 WILL BE AVAILABLE 69 AND SERVICES 69 TO MAINTAIN 69 SUPPORT TO 69 ON THE OCCASION 69 WILL INCREASE 69 LOOKS TO CONTINUE TO 69 TO STRENGTHEN 69 WILL REMAIN 69 STRENGTHENS 69 ARE NOW 69 BULLISH MOVING AVERAGE CROSSOVER 69 AND MAKE 69 RESEARCH AND 69 POTENTIALLY OVERVALUED IN TERMS 69 SET TO REBOUND AFTER 69 SMARTREND 68 DECLINE IN 68 STOCK ON 68 TO POST 68 OF THIS STORY 68 PULLBACK IN SHARES OF 68 SHARES DOWN 68 APPROACHES NEW UPSIDE TARGET 68 SMARTREND DETECTS CONTINUED BUYING 68 VOLUME SPIKE DETECTED IN

Back to home page